Hubei Goto Biopharm News

Kyodo Pharmaceutical: Announcement on not revising the Kyodo debt-for-equity conversion price downward

Feb 28 05:22 ET

Kyodo Pharmaceutical: An indicative announcement on Kyodo Bonds expected to trigger downward revision conditions for the share conversion price

Feb 21 05:46 ET

Kyodo Pharmaceutical: Announcement on the company\'s share repurchase plan and the letter of commitment to obtain a special loan to repurchase shares from financial institutions

Feb 21 05:22 ET

Kyodo Pharmaceutical: Dongfang Jincheng International Credit Evaluation Co., Ltd.\'s notice on the 2024 performance pre-loss of Hubei Kyodo Pharmaceutical Co., Ltd.

Feb 10 04:04 ET

Kyodo Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2024

Jan 2 02:56 ET

Kyodo Pharmaceutical: Announcement on the 2024 Interest Payment of Mutual Convertible Bonds

Nov 21, 2024 04:22 ET

Kyodo Pharmaceutical: Announcement on the Election of Staff Representative Supervisors for the 3rd Board of Supervisors

Oct 16, 2024 08:32 ET

Kyodo Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management

Oct 16, 2024 08:32 ET

Kyodo Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Oct 16, 2024 08:02 ET

Kyodo Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hubei Kyodo Pharmaceutical Co., Ltd.

Oct 16, 2024 08:02 ET

Kyodo Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024

Oct 8, 2024 04:16 ET

Kyodo Pharmaceutical: Announcement on the election of the board of directors for a new term

Sep 30, 2024 12:00 ET

Kyodo Pharmaceutical: Announcement on the election of the Supervisory Board for a new term

Sep 30, 2024 12:00 ET

Kyodo Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024

Sep 30, 2024 12:00 ET

Kyodo Pharmaceutical: Dongfang Jincheng International Credit Evaluation Co., Ltd.\'s notice on Hubei Kyodo Pharmaceutical Co., Ltd.\'s 2024 semi-annual performance loss

Sep 18, 2024 04:36 ET

Kyodo Pharmaceutical: Announcement on changing the sponsor representative for continuous supervision

Sep 13, 2024 05:02 ET

Kyodo Pharmaceutical: 2024 Semi-Annual Financial Report

Aug 27, 2024 12:00 ET

Kyodo Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024

Aug 27, 2024 12:00 ET

Hubei Goto Biopharm: Legal opinion from Beijing Zhonglun (Wuhan) Law Firm regarding the 2024 second extraordinary general meeting of shareholders of Hubei Jointown Pharmaceutical Co., Ltd.

Aug 9, 2024 06:24 ET

Hubei Goto Biopharm: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.

Aug 9, 2024 06:24 ET